FI934222A0 - Pyridazinonaettiksyror - Google Patents

Pyridazinonaettiksyror

Info

Publication number
FI934222A0
FI934222A0 FI934222A FI934222A FI934222A0 FI 934222 A0 FI934222 A0 FI 934222A0 FI 934222 A FI934222 A FI 934222A FI 934222 A FI934222 A FI 934222A FI 934222 A0 FI934222 A0 FI 934222A0
Authority
FI
Finland
Prior art keywords
pyridazinonaettiksyror
Prior art date
Application number
FI934222A
Other languages
English (en)
Other versions
FI934222A (fi
Inventor
Banavara L Mylari
William J Zembrowski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI934222A0 publication Critical patent/FI934222A0/fi
Publication of FI934222A publication Critical patent/FI934222A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI934222A 1991-03-28 1993-09-27 Pyridazinonaettiksyror FI934222A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67691991A 1991-03-28 1991-03-28
PCT/US1992/001603 WO1992017446A2 (en) 1991-03-28 1992-03-09 Pyridazinone acetic acids aldose reductase inhibitors

Publications (2)

Publication Number Publication Date
FI934222A0 true FI934222A0 (fi) 1993-09-27
FI934222A FI934222A (fi) 1993-09-27

Family

ID=24716565

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934222A FI934222A (fi) 1991-03-28 1993-09-27 Pyridazinonaettiksyror

Country Status (19)

Country Link
EP (1) EP0582643A1 (fi)
JP (1) JPH06500793A (fi)
CN (1) CN1065269A (fi)
AU (1) AU658887B2 (fi)
BR (1) BR9205810A (fi)
CA (1) CA2107104A1 (fi)
CZ (1) CZ387092A3 (fi)
DE (1) DE9290035U1 (fi)
FI (1) FI934222A (fi)
HU (1) HUT67836A (fi)
IE (1) IE920979A1 (fi)
IL (1) IL101325A0 (fi)
MX (1) MX9201414A (fi)
NZ (1) NZ242152A (fi)
PT (1) PT100301A (fi)
TW (1) TW207998B (fi)
WO (1) WO1992017446A2 (fi)
YU (1) YU30392A (fi)
ZA (1) ZA922238B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2240657T3 (es) * 2001-02-28 2005-10-16 Pfizer Products Inc. Compuestos de sulfonilpiridazinona utiles como inhibidores de aldosa reductasa.
SE0100873D0 (sv) * 2001-03-13 2001-03-13 Astrazeneca Ab Method of treatment
EE200300470A (et) 2001-03-30 2004-02-16 Pfizer Products Inc. Aldoosreduktaasi püridasinooninhibiitorid
AU761191B2 (en) * 2001-05-24 2003-05-29 Pfizer Products Inc. Therapies for tissue damage resulting from ischemia
US7572910B2 (en) 2003-02-20 2009-08-11 Pfizer, Inc. Pyridazinone aldose reductase inhibitors
CN111617072B (zh) * 2019-02-27 2023-06-20 苏州凯祥生物科技有限公司 一种高尿酸血症药物组合物及用于治疗高尿酸血症的药物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法
FR2647676A1 (fr) * 1989-06-05 1990-12-07 Union Pharma Scient Appl Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase

Also Published As

Publication number Publication date
WO1992017446A2 (en) 1992-10-15
CZ387092A3 (en) 1994-02-16
MX9201414A (es) 1992-10-01
AU658887B2 (en) 1995-05-04
NZ242152A (en) 1994-07-26
ZA922238B (en) 1993-09-27
AU1779692A (en) 1992-11-02
CN1065269A (zh) 1992-10-14
HU9302728D0 (en) 1993-12-28
BR9205810A (pt) 1994-06-28
YU30392A (sh) 1994-11-15
DE9290035U1 (de) 1993-11-18
PT100301A (pt) 1993-06-30
TW207998B (fi) 1993-06-21
IE920979A1 (en) 1992-10-07
HUT67836A (en) 1995-05-29
WO1992017446A3 (en) 1992-11-26
JPH06500793A (ja) 1994-01-27
EP0582643A1 (en) 1994-02-16
CA2107104A1 (en) 1992-09-29
IL101325A0 (en) 1992-11-15
FI934222A (fi) 1993-09-27

Similar Documents

Publication Publication Date Title
DE69133396D1 (de) Warenauszahlsystem
DE69212332D1 (de) Farbball
DE59206583D1 (de) Windsichter
ATE137279T1 (de) Stoffauflauf
DE59209950D1 (de) Flaschendispenser
DE69218585D1 (de) Anzeigetafel
BR9204511A (pt) Recolhedor-enrolador
DE59208716D1 (de) Lymphoides cd30-antigen
DE59207013D1 (de) Sportschuh
DE69126968D1 (de) Tamburin
ATA170491A (de) Mauerstein
ATA39792A (de) Maehwerk
FI934222A (fi) Pyridazinonaettiksyror
ATE163916T1 (de) Ethyl-6-formyloxy-4-hexenoat
ATA9892A (de) Formstein
ATA67791A (de) Rollski
BR9201945A (pt) Filatorio
CA68725S (fr) Mobilier-jeu
BR9100265A (pt) Assadeira multiutilitaria
BR9104939A (pt) Fute-tenis
BR7102423U (pt) Mic-lav
BR9100002A (pt) Candress
BR7101883U (pt) Boomerangue
BR9100610A (pt) Sandalia ortopedica magnetica
BR7101581U (pt) Calcopronto

Legal Events

Date Code Title Description
FD Application lapsed